Search Results

Filter
  • 1-10 of  4,426 results for ""Oxidopamine""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Decrease of K ATP channel expression through D3 receptor-mediated GSK3β signaling alleviates levodopa-induced dyskinesia (LID) in Parkinson's disease mouse model.

  • Authors : Kuo YY; Department of Physiology, College of Medicine, National Cheng Kung Univesity, Tainan 70101, Taiwan; Institue of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan.

Subjects: Levodopa*/Levodopa*/Levodopa*/adverse effects ; Glycogen Synthase Kinase 3 beta*/Glycogen Synthase Kinase 3 beta*/Glycogen Synthase Kinase 3 beta*/metabolism ; Dyskinesia, Drug-Induced*/Dyskinesia, Drug-Induced*/Dyskinesia, Drug-Induced*/metabolism

  • Source: Life sciences [Life Sci] 2024 Dec 15; Vol. 359, pp. 123255. Date of Electronic Publication: 2024 Nov 16.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0375521 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

AdipoRon improves mitochondrial homeostasis and protects dopaminergic neurons through activation of the AMPK signaling pathway in the 6-OHDA-lesioned rats.

  • Authors : Athari SZ; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Subjects: Dopaminergic Neurons*/Dopaminergic Neurons*/Dopaminergic Neurons*/drug effects ; Dopaminergic Neurons*/Dopaminergic Neurons*/Dopaminergic Neurons*/metabolism ; Dopaminergic Neurons*/Dopaminergic Neurons*/Dopaminergic Neurons*/pathology

  • Source: European journal of pharmacology [Eur J Pharmacol] 2024 Dec 15; Vol. 985, pp. 177111. Date of Electronic Publication: 2024 Nov 06.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Robust In Vitro Models for Studying Parkinson's Disease? LUHMES Cells and SH-SH5Y Cells.

  • Authors : Keighron CN; Cellular Physiology Research Lab, School of Medicine, Department of Physiology, University of Galway, H91W5P7 Galway, Ireland.; Avazzedeh S

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/metabolism ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/pathology ; Reactive Oxygen Species*/Reactive Oxygen Species*/Reactive Oxygen Species*/metabolism

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Dec 06; Vol. 25 (23). Date of Electronic Publication: 2024 Dec 06.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Cuparene-type sesquiterpenes with neuroprotective activities from the edible mushroom Flammulina filiformis.

  • Authors : Wu S; Western Guangdong Characteristic Biology and Medicine Engineering and Research Center, School of Chemistry and Chemical Engineering, Lingnan Normal University, Zhanjiang 524048, PR China.; Chen X

Subjects: Neuroprotective Agents*/Neuroprotective Agents*/Neuroprotective Agents*/pharmacology ; Neuroprotective Agents*/Neuroprotective Agents*/Neuroprotective Agents*/isolation & purification ; Sesquiterpenes*/Sesquiterpenes*/Sesquiterpenes*/pharmacology

  • Source: Fitoterapia [Fitoterapia] 2024 Dec; Vol. 179, pp. 106235. Date of Electronic Publication: 2024 Sep 23.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 16930290R Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Effect of Tiaoshen Changzhi acupuncture on behavior and striatum ΔFosB in rats with levodopa-induced dyskinesias.

  • Authors : Li Y; Heilongjiang University of Traditional Chinese Medicine, Harbin, China.; Zhu J

Subjects: Levodopa*/Levodopa*/Levodopa*/adverse effects ; Acupuncture Therapy*/Acupuncture Therapy*/Acupuncture Therapy*/methods ; Corpus Striatum*/Corpus Striatum*/Corpus Striatum*/metabolism

  • Source: Biotechnology & genetic engineering reviews [Biotechnol Genet Eng Rev] 2024 Dec; Vol. 40 (4), pp. 3916-3930. Date of Electronic Publication: 2023 May 22.Publisher: Taylor & Francis Country of Publication: England NLM ID: 8510274 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

HucMSC extracellular vesicles increasing SATB 1 to activate the Wnt/β-catenin pathway in 6-OHDA-induced Parkinson's disease model.

  • Authors : He Y; Medical College, Guangxi University, Nanning, China.; Department of Pharmacy, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China.

Subjects: Oxidopamine* ; Wnt Signaling Pathway* ; Extracellular Vesicles*/Extracellular Vesicles*/Extracellular Vesicles*/metabolism

  • Source: IUBMB life [IUBMB Life] 2024 Dec; Vol. 76 (12), pp. 1154-1174. Date of Electronic Publication: 2024 Jul 31.Publisher: Published for the International Union of Biochemistry and Molecular Biology by Taylor & Francis Country of Publication: England NLM ID: 100888706

Record details

×
Academic Journal

Stimulation of microneedles alleviates pathology of Parkinson's disease in mice by regulating the CD4+/CD8+ cells from the periphery to the brain.

  • Authors : Kim JH; Department of Biomedical and Pharmaceutical Sciences, Kyung Hee University, Seoul, Republic of Korea.; Choi Y

Subjects: Brain*/Brain*/Brain*/immunology ; Brain*/Brain*/Brain*/metabolism ; Brain*/Brain*/Brain*/pathology

  • Source: Frontiers in immunology [Front Immunol] 2024 Nov 19; Vol. 15, pp. 1454102. Date of Electronic Publication: 2024 Nov 19 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Identifying genetic targets in clinical subtypes of Parkinson's disease for optimizing pharmacological treatment strategies.

  • Authors : Kong D; State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Beijing Key Laboratory of Drug Target Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Li C

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/genetics ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/drug therapy ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/metabolism

  • Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2024 Nov 18; Vol. 9 (1), pp. 320. Date of Electronic Publication: 2024 Nov 18.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

GPR40 agonist ameliorates neurodegeneration and motor impairment by regulating NLRP3 inflammasome in Parkinson's disease animal models.

  • Authors : Ha TY; Neuroscience Research Institute, Gachon University, Incheon 21565, Republic of Korea; Department of Pharmacology, College of Medicine, Gachon University, Incheon 21999, Republic of Korea.

Subjects: Receptors, G-Protein-Coupled*/Receptors, G-Protein-Coupled*/Receptors, G-Protein-Coupled*/agonists ; Receptors, G-Protein-Coupled*/Receptors, G-Protein-Coupled*/Receptors, G-Protein-Coupled*/metabolism ; Mice, Inbred C57BL*

  • Source: Pharmacological research [Pharmacol Res] 2024 Nov; Vol. 209, pp. 107432. Date of Electronic Publication: 2024 Sep 21.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8907422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Oxyphylla A exerts antiparkinsonian effects by ameliorating 6-OHDA-induced mitochondrial dysfunction and dyskinesia in vitro and in vivo.

  • Authors : Shao M; School of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, China.; Zhao C

Subjects: Oxidopamine* ; Mitochondria*/Mitochondria*/Mitochondria*/drug effects ; Mitochondria*/Mitochondria*/Mitochondria*/metabolism

  • Source: Chemico-biological interactions [Chem Biol Interact] 2024 Nov 01; Vol. 403, pp. 111224. Date of Electronic Publication: 2024 Sep 03.Publisher: Elsevier Country of Publication: Ireland NLM ID: 0227276 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7786

Record details

×
  • 1-10 of  4,426 results for ""Oxidopamine""